Alpha-B-crystallin in neuropathology

Ophthalmologica

Volumn 214, Issue 1, 2000, Pages 7-12

  Van Rijk, A F ^a   Bloemendal, H ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

B crystallin; Heat shock protein; Neurodegenerative diseases

Indexed keywords

ALPHA CRYSTALLIN; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; GLIAL FIBRILLARY ACIDIC PROTEIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; MYELIN; NEUROFILAMENT PROTEIN; PROTEIN ANTIBODY; PROTEINASE; UBIQUITIN;

ALEXANDER DISEASE; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; DEGENERATIVE DISEASE; HUMAN; LENS; PROTEIN EXPRESSION; REVIEW;

ANIMALS; BIOLOGICAL MARKERS; BRAIN; CRYSTALLINS; HUMANS; NEURODEGENERATIVE DISEASES; NEURONS; PROGNOSIS; SPINAL CORD;

EID: 0033953446     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000027468     Document Type: Review

References (70)

1. Schoenmakers JJG, Bloemendal H: Subunits of α-crystallin from adult and embryonic cattle lens. Nature 1968;220:790-791.
2. Bloemendal H: Report on the biochemistry of the lens. Exp Eye Res 1969;8:227-240.
3. Clayton RM, Campbell JC, Truman DES: A reexamination of organ specific lens antigens. Exp Eye Res 1968;7:11-29.
4. Maisel H: The immunologic specificity of lens antigens. Am J Ophthalmol 1963;55:1208-1216.
5. Moscona AA, Fox L, Smith J, Degenstein L: Antiserum to lens antigens immunostains Muller glia cells in the neural retina. Proc Natl Acad Sci USA 1985;82:5570-5573.
6. Bhat SP, Nagineni CN: αB subunit of lens-specific protein α-crystallin is present in other ocular and non-ocular tissue. Biochem Biophys Res Commun 1989;158:319-325.
7. Kato K, Shinohara H, Kurobe N, Goto S, Inaguma Y, Ohshima K: Immunoreactive αA-crystallin in rat non-lenticular tissues is detected with a sensitive immunoassay system. Biochim Biophys Acta 1991;1080:173-180.
8. Ingolia TD, Craig EA: Four small heat-shock proteins are related to each other and to mammalian α-crystallin. Proc Natl Acad Sci USA 1982;79:2360-2364.
9. Horwitz J: α-Crystallin can function as a molecular chaperone. Proc Natl Acad Sci USA 1992;89:10449-10453.
10. de Jong WW, Caspers GJ, Leunissen JAM: Small heat-shock protein superfamily. Int J Biol Macromol 1998;22:151-162.
11. Anson F, Laborde JB, Pipkin JL, Hinson WG, Hanser DK, Sheehan M, Young JF: Target tissue specificity of retinoic acid induced stress proteins and malformations in mice. Teratology 1991;44:19-28.
12. Mayer R, Arnold J, Laszlo L, Landon M, Lowe L: Ubiquitin in health and disease. Biochim Biophys Acta 1991;1089:141-157.
13. Iwaki T, Wisniewski T, Iwaki A, Corbin E, Tomokane N, Tateishi J, Goldman JE: Accumulation of αB-crystallin in central nervous system glia and neurons in pathological conditions. Am J Pathol 1992;140:345-356.
14. Iwaki T, Iwaki A, Myazono M, Goldman JE: Preferential expression of αB-crystallin in astrocytic elements of neuroectodermal tumors. Cancer 1991;68:2230-2240.
15. Tomokane N, Iwaki T, Tateishi J, Iwaki A, Goldman JE: Rosenthal fibers share epitopes with αB-crystallin, glial fibrillary acidic protein, and ubiquitin, but not with vimentin. Am J Pathol 1991;138:875-885.
16. Renkawek K, Voorter CEM, Bosman GJCGM, van Workum FPA, de Jong WW: Expression of αB-crystallin in Alzheimer's disease. Acta Neuropathol 1994;87:155-160.
17. Aoyama A, Steiger RH, Fröhli E, Schäfer R, von Deimling, A, Wiestler OD, Klemenz R: Expression of αB-crystallin in human brain tumors. Int J Cancer 1993;55:760-764.
18. Lowe J, McDermott H, Pike I, Splendlove I, Landon M, Mayer RJ: αB-crystallin expression in non-lenticular tissues and selective presence in ubiquitinated inclusion bodies in human disease. J Pathol 1992;166:61-68.
19. Alexander WS: Progressive fibrinoid degeneration of fibrillary astrocytes in a hydrocephalic infant. Brain 1949;72:373-381.
20. Garret R, Ames RP: Alexander disease: Case report with electron microscopical studies and review of the literature. Arch Pathol 1974;98: 379-385.
21. Farrel K, Chuang S, Becker LE: Computed tomography in Alexander's disease. Ann Neurol 1984;15:605-607.
22. Ochi N, Kobayashi K, Meahara A, Negoro T, Shinohara H, Watanabe K, Nagatsu T, Kato K: Increment of αB-crystallin mRNA in the brain of patients with infantile type Alexander's disease. Biochem Biophys Res Commun 1991: 179:1030-1035.
23. Neal JW, Cave EM, Shingaro SK, Cole G, Wallace SJ: Alexander's disease in infancy and childhood: A report of two cases. Acta Neuropathol 1992;84:322-327.
24. Cole G, De Villiers F, Proctor NSF, Freiman I, Bill P: Alexander's disease: Case report including histopathological and electron microscopic features. J Neurol Neurosurg Psychiatry (Berl) 1979;42:163-166.
25. Escourolle R, de Baecque C, Gray F, Baumann N, Hauw JJ: Etude en microscopie électronique et neurochimique d'un cas de maladie d'Alexander. Acta Neuropathol (Berl) 1979;45: 133-140.
26. Arend AO, Leary PM, Rutherford GS: Alexander's disease: A case report with brain biopsy, ultrasound, CT scan and MRI findings. Clin Neuropathol 1991; 10:122-126.
27. Weissenböck H, Obermaier G, Dahme E: Alexander's disease in a Bernese mountain dog. Acta Neuropathol 1996;91:200-204.
28. Head MW, Corbin E, Goldman JE: Overexpression and abnormal modification of the stress proteins αB-crystallin and Hsp27 in Alexander's disease. Am J Pathol 1993;143: 1743-1753.
29. Herhko A, Eytan E, Ciechanover A: Immunochemical analysis of the turnover of ubiquitin-protein conjugates in intact cells: Relationship to the breakdown of abnormal proteins. J Biol Chem 1982;257:13964-13970.
30. Goldman JE, Corbin E: Rosenthal fibers contain ubiquitinated αB-crystallin. Am J Pathol 1991;139:933-938.
31. Rechsteiner M: Ubiquitin-mediated pathways for intracellular proteolysis. Annu Rev Cell Biol 1987;3:1-30.
32. Mulder DW, Kurland LT, Offord KP, Beard CM: Familial adult motor neuron disease: Amyotrophic lateral sclerosis. Neurology 1986; 36:511-517.
33. Siddique T, Pericak-Vance MA, Brooks BR, Roos RP, Hung WY, Antel JP, Munsat TL, Phillips K, Warner K, Speer M, Bias WB, Siddique NA, Roses AD: Linkage analysis in familial amyotrophic lateral sclerosis. Neurology 1989;39:919-925.
34. Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, Sisodia SS, Cleveland DW, Price DL: An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995;14:1105-1116.
35. Heads T, Pollock M, Robertson A, Sutherland WH, Allpress S: Sensory nerve pathology in amyotrophic lateral sclerosis. Acta Neuropathol 1991;82:316-320.
36. Horton WA, Eldridge R, Brody JA: Familial motor neuron disease: Evidence for at least three different types. Neurology 1976;26:460-465.
37. Deng HX, Hentati A, Tainer JA, Iqbal Z, Cayabyab A, Hung WY, Getzoff ED, Hu P, Herzfeldt B, Roos RP, Warner C, Deng G, Soriano E, Smyth C, Parge HE, Ahmed A, Roses AD, Hallewell RA, Perick-Vance MA, Siddique T: Amyotrophic lateral sclerosis and structural defects in Cu/Zn superoxide dismutase. Science 1993;261:1047-1051.
38. Roses Dr, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, Rahmani Z, Krizus A, McKenna-Yasek D, Cayabyab A, Caston SM, Berger R, Tanzi RE, Halperin JJ, Herzfeldt B, Van Den Bergh R, Hung WY, Bird T, Deng G, Mulder DW, Smyth C, Laing NG, Soriano E, Pericak-Vance MA, Haines J, Rouleau GA, Gusella JS, Horvitz H, Brown RH Jr: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59-62.
39. Brown RH Jr: Superoxide dismutase and oxidative stress in amyotrophic lateral sclerosis; in Oxidative Stress and the Molecular Biology of Antioxidant Defenses. Cold Spring Harbor, Cold Spring Harbor Laboratory Press, 1997, pp 569-586.
40. Rabizadeh S, Gralla E, Borchelt D, Gwinn R, Valentine JS, Sisodia S, Wong P, Lee M, Hahn H, Bredesen DE: Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: Studies in yeast and neural cells. Proc Natl Acad Sci USA 1995;92:3024-3028.
41. Carri MT, Battistoni A, Polizio F, Desideri A, Rotilio G: Impaired copper binding by the H46R mutant of Cu/Zn superoxide dismutase involved in amyotrophic lateral sclerosis. FEBS Lett 1994;356:314-316.
42. Kato S, Hirano A, Umahara T, Kato M, Herz F, Ohama E: Comparative histochemical study on the expression of αB-crystallin, ubiquitin and stress response protein 27 in ballooned neurons in various disorders. Neuropathol Appl Neurobiol 1992;18:335-340.
43. Kawashima T, Kikuchi H, Takita M, Dohura K, Ogomori K, Oda M, Iwaki T: Skein-like inclusions in the neostriatum from a case of amyotrophic lateral sclerosis with dementia. Acta Neuropathol 1998;117:541-545.
44. Arima K, Ogawa M, Sunohara N, Nishio T, Shimomura Y, Hirai S, Eto K: Immunohistochemical and ultrastructural characterization of ubiquitinated eosinophilic fibrillary neuronal inclusions in sporadic amyotrophic lateral sclerosis. Acta Neuropathol Berl 1998;96:75-85.
45. Selkoe DJ: Cell biology of the beta-protein precursor and the mechanism of Alzheimer's disease. Annu Rev Cell Biol 1994;10:373-403.
46. Johnston JA, Cowburn RF, Norgren S, Wiehager B, Venizelos N, Winblad B, Vigo Pelfrey C, Schenk D, Lannfelt L, O'Neill C: Increased β-amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease APP670/671 mutation. FEBS Lett 1994;354:274-278.
47. Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J, Hutton M, Kukull W, Larson E, Levy-Lahad E, Viitanen M, Peskind E, Poorkaj P, Schellenberg G, Tanzi R, Wasco W, Lannfelt L, Selkoe D, Younkin S: Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 1996;2:864-870.
48. Jarrett JT, Berger EP, Lansbury PT Jr: The carboxy terminus of the β-amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease. Biochemistry 1993;32:4693-4697.
49. Lansbury PT Jr: Consequences of the molecular mechanism of amyloid formation for the understanding of the pathogenesis of Alzheimer's disease and the development of therapeutic strategies. Arzneimittel Forschung 1995;45: 432-434.
50. Renkawek K, de Jong WW, Merck KB, Frenken CW, van Workum FP, Bosman GJCGM: αB-Crystallin is present in reactive glia in Creutzfeldt-Jakob disease. Acta Neuropathol Berl 1992;83:324-327.
51. Rubinsztein DC: The genetics of Alzheimer's disease. ProgNeurobiol 1997;52:447-454.
52. Stege GJJ, Bosman GJCGM: The Biochemistry of Alzheimer's disease. Drugs Aging 1999; 14:437-446.
53. Wisniewski KE, Wisniewski HM, Wen GY: Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol 1985;17:278-282.
54. Heston LL: Alzheimer's disease, trisomy 21 and myeloproliferative disorders: Associations suggesting a genetic diathesis. Science 1977; 196:322-323.
55. Ball MJ, Nuttall K: Neurofibrillary tangles, granulovacuolar degeneration, and neuron loss in Down syndrome: Quantitative comparison with Alzheimer's dementia. Ann Neurol 1980; 7:462-465.
56. Yates CM, Simpson J, Gordon A: Regional brain 5-hydroxytryptamine levels are reduced in senile Down's syndrome as in Alzheimer's disease. Neurosci Lett 1986;65:189-192.
57. Renkawek K, van Workum FAP, de Jong WW: Immunohistochemical expression of αB-crystallin and heat shock protein 27 in the brain in Down syndrome. Dev Brain Dysfunct 1995;8: 35-39.
58. Stege GJJ, Renkawek K, Overkamp PSG, Verschuure P, Van Rijk AF, Reijnen-Aalbers A, Boelens WC, Bosman GJCGM, de Jong WW: The molecular chaperone alpha B-crystallin enhances amyloid beta neurotoxicity. Biochem Biophys Res Comm 1999;262:152-156.
59. Lowe J: Establishing a pathological diagnosis in degenerative dementias. Brain Pathol 1998;8: 403-406.
60. Kato S, Hirano A, Umahara T, Llena JF, Herz F, Ohama E: Ultrastructural and immunohistochemical studies on ballooned cortical neurons in Creutzfeldt-Jakob disease: Expression of αB-crystallin, ubiquitin and stress-response protein 27. Acta Neuropathol Berl 1992;84: 443-448.
61. Tamaoka A, Mizusawa H, Mori H, Shoji S: Ubiquitinated αB-crystallin in glial cytoplasmic inclusions from the brain of a patient with multiple system atrophy. J Neurol Sci 1995; 129:192-198.
62. van Noort JM: Multiple sclerosis: An altered immune response or an altered stress response. J Mol Med 1996;74:285-296.
63. van Noort JM, van Sechel AC, Bajramovic JJ, Elouagmiri M, Polman CH, Lassmann H, Ravid R: The small heat-shock protein αB-crystallin as candidate autoantigen in multiple sclerosis. Nature 1995;375:798-801.
64. Bajramovic JJ, Lassmann H, van Noort JM: Expression of αB-crystallin in glia cells during lesional development in multiple sclerosis. J Neuroimmunol 1997;78:143-151
65. Boccaccio GL, Steinman L: Multiple sclerosis - From a myelin point of view. J Neurosci Res 1996;45:647-654.
66. Matsumoto S, Udaka F, Kameyama M, Kusaka H, Ito H, Imai T: Subcortical neurofibrillary tangles, neuropil threads, and argentophilic glial inclusions in corticobasal degeneration. Clin Neuropathol 1996;15:209-214.
67. Mori H, Oda M, Mizuno Y: Cortical ballooned neurons in progressive supranuclear palsy. Neurosci Lett 1996;209:109-112.
68. Tolnay M, Probst A: Ballooned neurons expressing αB-crystallin as a constant feature of the amygdala in argyrophilic grain disease. Neurosci Lett 1998;246:165-168.
69. Mizutani T, Inose T, Nakajima S, Kakimi S, Uchigata M, Ikeda K, Gambetti P, Takasu T: Familial parkinsonism and dementia with ballooned neurons, argyrophilic neuronal inclusions, atypical neurofibrillary tangles, tau-negative astrocytic fibrillary tangles, and Lewy bodies. Acta Neuropathol Berl 1998;95:15-27.
70. Renkawek K, Bosman GJCGM, de Jong WW: Expression of the small heat shock protein HSP27 in reactive gliosis in Alzheimer disease and other types of dementia. Acta Neuropathol 1994;87:511-519.